Position in IVA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$378,000
New position
Shares Held
100,000
first reported quarter
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 8 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rathbones Group PLC holds $10,663,603 across 18 Biotechnology names. IVA ranks #9 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
23,500 | $1,916,895 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
163,220 | $1,428,991 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
23,166 | $1,398,299 | |
| 4 | ORMP |
Oramed Pharmaceuticals Inc.
|
233,018 | $1,120,816 | |
| 5 | DFTX |
Definium Therapeutics, Inc.
|
22,800 | $1,072,512 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
11,790 | $1,025,140 | |
| 7 | MRNA |
Moderna, Inc.
|
9,474 | $663,464 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,044 | $518,586 |
All Filings in IVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $378,000 | 100,000 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||